KM

Kelly McGlinchey

AstraZeneca (Japan) JP

ORCID iD 0000-0002-4969-5523
84
Publications
1,606
Citations
20
H-Index
27
i10-Index
1.0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

No publications found.

Research Topics

Cancer Immunotherapy and Biomarkers (29) Monoclonal and Polyclonal Antibodies Research (20) Immune Cell Function and Interaction (16) CAR-T cell therapy research (15) Glioma Diagnosis and Treatment (13)

Affiliations

Bristol-Myers Squibb (Germany)
DE 2008 - 2008
Bristol-Myers Squibb (United States)
US 2015 - 2004
AstraZeneca (Netherlands)
NL 2022 - 2021
AstraZeneca (Japan)
JP 2024 - 2020
Altimmune (United States)
US 2018 - 2017

Share Profile

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now